Published in Medical Letter on the CDC and FDA, June 8th, 2003
West Nile Virus is spread to humans via mosquitoes and blood transfusion.
Under the licensing agreement, CDC will provide Spectral with reagents, consisting of antibodies, antigens, and scientific support in exchange for future royalties on in-market sales. Spectral plans to utilize its expertise in point-of-care diagnostics to develop a WNV test on its existing STATus platform, as well as its novel finger-prick based microfluidic platforms.
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Letter on the CDC and FDA
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.